Literature DB >> 17675807

Measurement of intestinal mucosal permeability in dogs with lymphocytic-plasmacytic enteritis.

Saku Kobayashi1, Koichi Ohno, Koji Uetsuka, Ko Nakashima, Asuka Setoguchi, Yasuhito Fujino, Hajime Tsujimoto.   

Abstract

Lymphocytic-plasmacytic enteritis (LPE) is a type of canine inflammatory bowel disease (IBD). One of its most probable causes is a defect in the mucosal permeability barrier. In the present study, intestinal permeability in LPE dogs was examinated to evaluate its clinical value. Twenty-nine dogs with LPE diagnosed by clinical and histological examinations were included in this study. Intestinal permeability was evaluated by measuring the ratio of the concentrations of two sugars (lactulose (L) and rhamnose (R)) with different molecular weights in urine samples after oral administration of a solution containing them. Biopsy specimens of duodenum were evaluated according to histological criteria. The urinary L:R ratio in the 29 LPE dogs (1.68 +/- 1.17, mean +/- SD) was significantly higher than that in the 10 healthy control dogs (0.75 +/- 0.38, P<0.01). In the LPE dogs, a weak correlation was observed between the histopathological grading score of the duodenum and the urinary L:R ratio (r=0.408, P<0.05). The urinary L:R ratio in the 20 dogs showing hypoalbuminemia (< 2.5 g/dl) was significantly higher than that in the 9 dogs with normal serum albumin levels > 2.5 g/dl (P<0.01). In conclusion, permeability of the intestinal mucosa as determined by the urinary L:R ratio could be a useful laboratory parameter for evaluating intestinal damage in LPE dogs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675807     DOI: 10.1292/jvms.69.745

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  7 in total

Review 1.  Inflammatory bowel disease in the dog: differences and similarities with humans.

Authors:  Matteo Cerquetella; Andrea Spaterna; Fulvio Laus; Beniamino Tesei; Giacomo Rossi; Elisabetta Antonelli; Vincenzo Villanacci; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

Review 2.  Nonpharmacological Treatment Strategies for the Management of Canine Chronic Inflammatory Enteropathy-A Narrative Review.

Authors:  Marco Isidori; Ronald Jan Corbee; Massimo Trabalza-Marinucci
Journal:  Vet Sci       Date:  2022-01-20

3.  Utility of the combined use of 3 serologic markers in the diagnosis and monitoring of chronic enteropathies in dogs.

Authors:  Juan Estruch; Jacqueline Johnson; Sarah Ford; Sean Yoshimoto; Tracy Mills; Philip Bergman
Journal:  J Vet Intern Med       Date:  2021-05-07       Impact factor: 3.333

4.  Effect of interleukin-1β on occludin mRNA expression in the duodenal and colonic mucosa of dogs with inflammatory bowel disease.

Authors:  Misato Ogawa; Hironari Osada; Ayana Hasegawa; Hikaru Ohno; Nanako Yanuma; Kazuaki Sasaki; Minoru Shimoda; Junsuke Shirai; Hirotaka Kondo; Keitaro Ohmori
Journal:  J Vet Intern Med       Date:  2018-03-23       Impact factor: 3.333

Review 5.  Laboratory tests for diagnosis of gastrointestinal and pancreatic diseases.

Authors:  Olivier Dossin
Journal:  Top Companion Anim Med       Date:  2011-05

Review 6.  Harnessing the Biology of Canine Intestinal Organoids to Heighten Understanding of Inflammatory Bowel Disease Pathogenesis and Accelerate Drug Discovery: A One Health Approach.

Authors:  Jamie J Kopper; Chelsea Iennarella-Servantez; Albert E Jergens; Dipak K Sahoo; Emilie Guillot; Agnes Bourgois-Mochel; Marilyn N Martinez; Karin Allenspach; Jonathan P Mochel
Journal:  Front Toxicol       Date:  2021-11-10

Review 7.  Canine chronic enteropathy-Current state-of-the-art and emerging concepts.

Authors:  Albert E Jergens; Romy M Heilmann
Journal:  Front Vet Sci       Date:  2022-09-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.